Clinical trials are conducted on human patients, already stricken with affliction this compound is supposed to cure. To prove the efficiency subjects are divided into two groups. One group who receives the tested compound and another which is administered placebo. Placebo is given to patients so reference data could be acquired in regard to effectiveness of the compound. Subjects are not informed to what group they belong.

Acomplia (Rimonabant) has successfully passed both preclinical and clinical trial. To provide safe and accurate data clinical trial for Rimonabant was conducted in three consecutive phases.

• Phase one – During phase one Rimonabants safety was assessed in reference to its evolvement within the body, the tolerance limit and undesirable events.
• Phase two – Second phase was conducted to determine efficiency and optimal dosage regime.
• Phase tree – During phase three Rimonabant was scrutinized in reference to its characteristics as; weight loss/weight maintenance treatment, avoidance of weight regain after preceding weight loss, and improvement of risk factors related to obesity.

Once the compound is approved by regulatory agencies like U.S. Food and Drug Administration for treating specific ailments the testing does not cease. Studies on the drug’s effectiveness, therapeutic value and safety are conducted during its marketing life.

generic acomplia

© admin for Generic Acomplia, 2008. | Permalink | No comment

Add to del.icio.us

Search blogs linking this post with Technorati

Want more on these topics ? Browse the archive of posts filed under generic acomplia.

In recent years weight loss has become one of the most talked about subjects in the media. A new revolutionary diet book comes out every month. Miracle herbal supplements promising thin, muscular bodies are everywhere in drug stores and now even supermarkets. But unfortunately they do not work. They don’t work because they do not target the root of weight problem, appetite. With all of the diets we are told to eat less food, but our bodies just do not listen.

French pharmaceutical company Sanofi – Aventis has come up with the solution to this problem. Studying the appetite itself, scientist from Sanofi – Aventis discovered that cannabis enhances appetite. Cannabis smokers call this enhanced desire for food “munchies”. Result of this research is the drug called Acomplia (Rimonabant).

Acomplia (Rimonabant) is the first drug on the market developed specifically to suppress appetite. It works by blocking the CB-1 receptors, which are found in the brain in addition to some of the body’s peripheral tissues such as fat cells, and are responsible for controlling appetite and dependency phenomenon.

Further study of this revolutionary drug has discovered that besides from being appetite suppressant, Acomplia (Rimonabant), can be used to treat smoking cessation and is also beneficial for cardiovascular/metabolic risk factors associated with obesity.

Acomplia (Rimonabant) is oral prescription medication usually taken in the morning before breakfast with full glass of water. Acomplia pill must be swallowed and not chewed. The usual prescribed daily dosage is 20mg. Acomplia must be taken regularly and not skipped. If a dose is skipped it should be taken immediately. Users should not overdose on the pill.

Although, Acomplia Rimonabant has been proven as successful weight loss treatment it must be accompanied with regular exercise routine and low-calorie diet.

Acomplia (Rimonabant) should not be used by nursing mothers and pregnant women. Inform your physician and your OBGYN before consuming Acomplia. Also ask him to explain side effects associated with Acomplia.

Side effects are generally mild and diminish in time. They might include nausea, irritability, anxiety, vomiting, stomach upset, muscle cramps. Side effects are temporary and fade away as soon as one adjusts to the Acomplia. If these side effects persist for an extended phase of time or any other critical side effects appear, seek instantaneous medical support.

rimonabant

© admin for Generic Acomplia, 2008. | Permalink | One comment

Add to del.icio.us

Search blogs linking this post with Technorati

Want more on these topics ? Browse the archive of posts filed under rimonabant.

Weight loss in obese individuals is of outmost importance. It starts with setting realistic goals and making sometimes difficult lifestyle changes. Changes have to include fewer calories intake and being more physically active. With obese patients medication and surgery is sometimes used to help with weight loss.

Rimonabant, a new obesity treatment, is on the wish list of millions of people worldwide. It is new revolutionary drug for quickest and most effective removal of excessive body fat. Rimonabant is an anorectic oral prescription drug, which regulates appetite and nicotine intake in the body. It works by inhibiting the CB-1 receptors in body, this result as a loss of appetite and patients eat less food than normal. Besides being obesity treatment, Rimonabant is also effective smoking cessation drug. Rimonabant must be accompanied with a low-calorie diet and regular fitness regime to get satisfactory weight loss results.

Usual prescription of Rimonabant is 20 mg per day. Pill should be swallowed with a full glass of water prior to breakfast and never chewed. It should be taken on time daily and never skipped. If you skip a dosage, take it as soon as you remember, but do not overdose. Try not to miss any dose, but if accidently skip the dosage, never try to compensate it by overdosing. Overdosing on Rimonabant or any other drug can be harmful for health.

Just as with any medication, Rimonabant can also cause some side effects. Side effects accompanying Rimonabant are rare, mild and in most cases temporary. Dizziness, nausea, stomach disorder and muscular cramps can accompany Rimonabant weight loss pill. These side effects are short lived and disappear after a few days use.

Recent studies in Rimonabant have discovered that besides from helping with smoke cessation and weight loss, there is also evidence that it helps with lipid levels (such as cholesterol) in the blood and might help with other metabolism-related health problems.

Before you go ahead with Rimonabant medication, prior conversation with your doctor is suggested to stay away from any future harmful repercussions. Consult your physician and your pharmacist. Inform them of any prescription drugs, over the counter medication, or supplements you are taking. Heart patients, diabetics, expectant women, women with child-bearing potential, and breast-feeding mothers should abstain from the intake of Rimonabant pill.

generic acomplia

© admin for Generic Acomplia, 2008. | Permalink | One comment

Add to del.icio.us

Search blogs linking this post with Technorati

Want more on these topics ? Browse the archive of posts filed under generic acomplia.

For people with a BMI of 30 or more, everyday life can become an ordeal. Struggling with weight can destroy self esteem, hamper relationships, and even threaten a person’s health. For many, simply trying to diet and exercise is not enough as cravings for food overwhelm even the most concerted attempts at weight loss, and any weight lost through willpower alone is often put back on within months or years.

Fortunately there is a medication available that can help curb the insatiable cravings that cause some people to eat themselves into an early grave. Generic Zimulti acts on the endocannibinoid system, the neurological system responsible for cravings. Though generic Zimulti is primarily designed as an appetite suppressant, it has also been shown to also reduce cravings for cigarettes, cocaine, alcohol, and opiates.

Like most medications, Generic Zimulti does cause side effects, the most noted of which are depression and anxiety. Because this drug acts on the central nervous system it can occasionally have unpredictable effects. Some patients experience a small amount of depression, which clears quickly, whilst others can become severely depressed, anxious, and even suicidal. For this reason, it is important to monitor oneself honestly, and also to be supervised by a qualified medical professional during the course of generic Zimulti. If at any point depression or anxiety become too severe, a person may be weaned off the drug and another avenue of weight loss found.

Also known as Rimonabant, Acomplia, Slimona, Rimoslim, Bethim, Monaslim, Remonabent, and Riobant, generic Zimulti is simply another term for the synthetic compound, 5-(4-Chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide. Therefore it is equally as effective as the brand name product that is sold at a significantly higher price.

Starting a course of generic Zimulti is no light undertaking. It is not uncommon for a course of generic Zimulti to last two years or more. During this time the patient must also make a commitment to good diet and a reasonable exercise routine. On its own, generic Zimulti will not aid a patient greatly, the responsibility for eating well and exercising properly still falls on the user, and both are necessary for weight loss to occur. This is made easier as people using generic Zimulti simply find that they are no longer plagued with the sorts of uncontrollable cravings for food that may have seen them binging in the past.

Though commitment and discipline are required in order for generic Zimulti to have an effect, the regime itself is relatively simple. A typical regime of generic Zimulti consists of one 20mg pill daily at breakfast time. If a pill is skipped it should not be doubled up on, as the effects on mood and other functions of the central nervous system may be unpredictable.

If you know that the time has come to lose weight, but traditional weight loss methods have failed you, and you have a BMI of 30 or more, or a BMI of 27 with additional risk factors (such as type 2 diabetes), then generic Zimulti may be the little helper you need to shed those excess pounds and enjoy a normal, healthy life once more.

As overweight people are all too aware, the effects of obesity can be far reaching and pervasive, but medical advances now mean that there is help available for those willing to make a serious commitment to losing weight and regaining their health. For millions of people worldwide, generic Zimulti has been a major key in their weight loss success. It could be the key to yours too.

rimonabant

© admin for Generic Acomplia, 2008. | Permalink | One comment

Add to del.icio.us

Search blogs linking this post with Technorati

Want more on these topics ? Browse the archive of posts filed under rimonabant.

Clinical trials are undertaken to demonstrate both the effectiveness and the safety of a drug for human consumption. Human clinical trials will only occur after substantial testing in pre clinical studies has demonstrated the likely effectiveness and safety of the medication to be tested. This final clinical trial will help to determine the most effective dosage and administration regimens, and will help to identify any toxicity in the drug. This human clinical trials stage will also allow for the documentation and categorization of side effects and other adverse reactions to the medication.

The drug Acomplia (rimonabant) was tested in three phases

Phase 1, was used to document and asses the general safety of the drug. Researchers measured the metabolic evolvement of the drug within the body and observed data pertaining to tolerance reactions and any adverse reactions or undesirable side effects.

Phase 2, was used to determine the best dosage regimen and the general effectiveness of rimonabanmt.

Phase 3, Was used to evaluate the efficacy of the medication as regards to weight loss assistance, obesity control and weight maintenance. The drug was evaluated on how well it allowed to people to maintain any weight loss that occurred through the drug’s usage, and the drug’s performance was measured against selected risk factors to obesity.

These trials will continue throughout the lifespan of a drug, and are not stopped after the drug achieves regulatory approval for sale.

rimonabant

© admin for Generic Acomplia, 2008. | Permalink | No comment

Add to del.icio.us

Search blogs linking this post with Technorati

Want more on these topics ? Browse the archive of posts filed under rimonabant.